Bringing biocatalysis into the deuteration toolbox J. S. Rowbotham,1 O. Lenz,2 H. A. Reeve1* and K. A. Vincent1* 1Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford, OX1 3QR, United Kingdom 2Department of Chemistry, Technische Universität Berlin, Strasse des 17. Juni 135, 10623 Berlin, Germany *Correspondence to:
[email protected],
[email protected] Chemicals labelled with the heavy hydrogen isotope deuterium (2H) have long been used in chemical and biochemical mechanistic studies, spectroscopy, and as analytical tracers.1 More recently, demonstration of selectively deuterated drug candidates that exhibit advantageous pharmacological traits has spurred innovations in metal-catalysed 2H insertion at targeted sites,2–5 but asymmetric deuteration remains a key challenge.6–8 Here we demonstrate an easy-to-implement biocatalytic deuteration strategy, achieving 2 high chemo-, enantio- and isotopic selectivity, requiring only H2O (D2O) and unlabelled dihydrogen under ambient conditions. The vast library of enzymes established for NADH-dependent C=O, C=C, and C=N bond reductions9 have yet to appear in the toolbox of commonly employed 2H-labelling techniques due to requirements for suitable deuterated reducing equivalents.10 By facilitating transfer of deuterium atoms from 2 + H2O solvent to NAD , with H2 gas as a clean reductant, we open up biocatalysis for asymmetric reductive deuteration as part of a synthetic pathway or in late stage functionalisation. We demonstrate enantioselective